Unlocking an Affordable Future: Key #2 Support and Equip Clinicians SUPPORT AND EQUIP CLINICIANS WITH TOOLS AND DATA TO SERVE PATIENTS OPTIMALLY Physicians, pharmacists, and other health care providers are valued employees within pharmacy benefit companies and esteemed healthcare partners outside
JC Scott (00:08): Welcome to the Pharmacy Benefit, a podcast where we talk about issues impacting patients, consumers, and affordable access to prescription drugs and better healthcare through the work being done by pharmacy benefit managers or PBMs. I’m
The so-called “delinking” policy made news last week with the introduction of H.R. 6283. Among several glaring problems — including a rejection of free market performance-based incentives that lower drug costs for consumers — if enacted, “delinking” would hand a
PBMs: Committed to Helping Patients The Critical Path Forward: Rx Policies to Reduce Patient Costs, Improve Access For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans. But more can
Newsroom Read More with Amanda Frost VIEW MORE VIEW MORE FROM JC SCOTT Katie Payne Senior Vice President, Public Affairs kpayne@pcmanet.org Greg Lopes Vice President, Public Affairs glopes@pcmanet.org 202-756-5713 Mike Baldyga Director, Public Affairs mbaldyga@pcmanet.org 202-756-5714 FOR YOUR INFORMATION The
The PCMA Business Forum 2024 took place at the Signia by Hilton Orlando, Bonnet Creek in Orlando, FL, on March 11 & 12. Don’t miss the industry’s most important business development, networking and educational conference. The Business Forum is a
Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by double-digit percentages since 2012 and cost Medicare and Medicaid nearly $12 billion in 2016, a Kaiser Health News analysis has
So-called “delinking” policies continue to be discussed in Congress. Among several glaring problems — including a rejection of free market performance-based incentives that lower drug costs for consumers — if enacted, “delinking” would hand a financial windfall totaling up to
©2024 PCMA. All Rights Reserved.
